Genistein and 17β-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2597-2603

  Lechner, Daniel ^a   Bajna, Erika ^a   Adlercreutz, Herman ^b   Cross, Heide S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cancer prevention; Catabolic 25 D 3 24 hydroxylase; Estrogen receptors; Phytoestrogens; Synthesizing 25 D3 1 hydroxylase

Indexed keywords

CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 24; CYTOCHROME P450 27B1; EQUOL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; ISOFLAVONE DERIVATIVE; MESSENGER RNA; UNCLASSIFIED DRUG; VITAMIN D; CALCIDIOL 1 MONOOXYGENASE; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CELL STRAIN CACO 2; CELL STRAIN MCF 7; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VITAMIN D METABOLISM; BIOSYNTHESIS; BREAST TUMOR; COLON TUMOR; GENETICS; METABOLISM; TUMOR CELL LINE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; BREAST NEOPLASMS; CACO-2 CELLS; CALCITRIOL; CELL LINE, TUMOR; COLONIC NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; HUMANS; ISOFLAVONES; RNA, MESSENGER; STEROID HYDROXYLASES;

EID: 33746638482     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM and Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama 288: 321-333, 2002.
2. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S and Mysiw WJ: Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. Jama 289: 2673-2684, 2003.
3. Messina MJ, Persky V, Setchell KD and Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21: 113-131, 1994.
4. Lechner D, Kallay E and Cross HS: Phytoestrogens and colorectal cancer prevention. Vitam Horm 70: 169-198, 2005.
5. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N and Leitman DC: Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276: 17808-17814, 2001.
6. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B and Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263, 1998.
7. Murkies AL, Wilcox G and Davis SR: Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 83: 297-303, 1998.
8. Atkinson C, Frankenfeld CL and Lampe JW: Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230: 155-170, 2005.
9. Frankenfeld CL, McTiernan A, Aiello EJ, Thomas WK, LaCroix K, Schramm J, Schwartz SM, Holt VL and Lampe JW: Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev 13: 1156-1162, 2004.
10. 3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol 62: 21-28, 1997.
11. Bareis P, Bises G, Bischof MG, Cross HS and Peterlik M: 25-hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 255: 1012-1017, 2001.
12. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E and Peterlik M: 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66: 287-292, 2001.
13. 3-1alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004.
14. Johnson CS, Hershberger PA, Bernardi RJ, McGuire TF and Trump DL: Vitamin D receptor: a potential target for intervention. Urology 60: 123-130; discussion 130-121, 2002.
15. Sheinin Y, Kaserer K, Wrba F, Wenzl E, Kriwanek S, Peterlik M and Cross HS: In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch 437: 501-507, 2000.
16. Kallay E, Adlercreutz H, Farhan H, Lechner D, Bajna E, Gerdenitsch W, Campbell M and Cross HS: Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumor prevention and therapy. J Nutr 132: 3490S-3493S, 2002.
17. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H and Armbrecht HJ: Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 134: 1207S-1212S, 2004.
18. Bischof MG, Siu-Caldera ML, Weiskopf A, Vouros P, Cross HS, Peterlik M and Reddy GS: Differentiation-related pathways of 1 alpha,25- dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: production of 1 alpha,25-dihydroxy-3epi-cholecalciferol. Exp Cell Res 241: 194-201, 1998.
19. Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Potzi C, Manhardt T, Bland R and Cross HS: Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Exp Cell Res 276: 320-327, 2002.
20. Farhan H, Wahala K, Adlercreutz H and Cross HS: Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci 777: 261-268, 2002.
21. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M and Masamune Y: Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 24: 351-356, 2001.
22. Harris DM, Besselink E, Henning SM, Go VL and Heber D: Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood) 230: 558-568, 2005.
23. Matsumura A, Ghosh A, Pope GS and Darbre PD: Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 94: 431-443, 2005.
24. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H and Bowey EA: Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36: 27-32, 2000.
25. Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ and Heubi JE: S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81: 1072-1079, 2005.